DB05572InvestigationalSmall molecule
TPI-ASM8 was under investigation in clinical trials NCT00822861, NCT01158898, NCT00402948, and NCT00550797, all for the treatment of Asthma.
- Mechanism
- Curator reviewed
Pharmacologically active on Cytokine receptor common subunit beta and C-C chemokine receptor type 3
- Primary indication
- Investigated for use/treatment in asthma.Curator reviewed
- Code names
- ASM8 · TPI-ASM8
Resolves to
Targets
What you can answer from here — as of July 03, 2026
Which drugs share a target with TPI-ASM8, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account